Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2003
05/22/2003CA2463639A1 Growth hormone variations in humans and their uses
05/22/2003CA2460959A1 Enzymes
05/22/2003CA2454031A1 Novel chromophores/fluorophores and methods for using the same
05/21/2003EP1312920A1 Method of screening remedy for heart failure
05/21/2003EP1311707A2 Mass spectrometric analysis of biopolymers
05/21/2003EP1311686A2 Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization
05/21/2003EP1311680A2 Nucleic acid molecules encoding plant cell cycle proteins and uses therefor
05/21/2003EP1311679A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
05/21/2003EP1311677A2 Regulation of human p2y1-like g protein-coupled receptor
05/21/2003EP1311674A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311673A2 Compositions and methods for the therapy and diagnosis of prostate cancer
05/21/2003EP1311668A2 Compositions and methods for the diagnosis and treatment of tumor
05/21/2003EP1311665A2 Kidney-specific protein
05/21/2003EP1311664A2 Microtubule-associated proteins and tubulins
05/21/2003EP1311663A2 Claudin polypeptides
05/21/2003EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
05/21/2003EP1311537A2 Identification of a cam-kinase ii inhibitor
05/21/2003EP1311529A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof
05/21/2003EP1311282A1 High affinity integrin polypeptides and uses thereof
05/21/2003EP1311281A1 Antimicrobial sulfonamide derivatives of lipopeptide antibiotics
05/21/2003EP1311163A2 Improved insecticidal bacteria, and methods for making and using them
05/21/2003EP1311162A2 Bacillus thurigiensis crystal protein hybrids
05/21/2003EP0866801B1 Cyclopeptolides
05/21/2003EP0720618B1 Process for the purification of basic fibroblast growth factor
05/21/2003EP0707650B1 Process for producing human relaxin
05/21/2003EP0633931B1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
05/21/2003EP0573551B1 Serine-rich peptide linkers
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419416A Cultured protein hydrolysate
05/21/2003CN1418965A Process for preparing human follicle-stimualting hormone beta subunit monoclonal antibody
05/21/2003CN1418964A Productive method of recombinant human liver regenerated enhanced factor and use in treating serious hepatopathy thereof
05/21/2003CN1418955A High temp. resistant FtsA protein gene and coded polypeptide and preparation process thereof
05/21/2003CN1109106C Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them
05/20/2003US6566499 Adipocyte-specific protein homologs
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566325 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases
05/20/2003US6566117 Immortal cell line derived from grouper Epinephelus coioides and its applications therein
05/20/2003US6566116 Enzymatic polypeptide for use in the treatment of diabetic nephropathy, glomerulonephritis, fibrosis, liver and kidney disorders, osteoporosis and lung disorders
05/20/2003US6566110 Nucleotide sequences coding polypeptide for use tool in halogenating compounds
05/20/2003US6566099 Nucleotide sequences coding polypeptide for use in the treatment of lysosomal storage disease
05/20/2003US6566097 Polypeptide for use in the treatment of mammalian viral diseases
05/20/2003US6566092 Nucleotide sequences coding polypeptide for use in the treatment nervous system disorders
05/20/2003US6566087 Detection of preferential enzymatic polypeptide; obtain sample containing enzymatic polypeptide, expose to modulator, monitor binding, detect adjustment in enzyme activity
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6566070 Detecting preferential protein biosynthesis; label nucleotide sequences, mix with translation system, incubate, detct signal from protein
05/20/2003US6565857 Coding human leukocyte antigen; anticancer, antitumor agent
05/20/2003US6565856 Polypeptide; inducting immunology response
05/20/2003US6565855 Polypeptides; genetic engineering
05/20/2003US6565848 Cadherin-like asymmetry protein-1, and methods for its use
05/20/2003US6565827 Anticarcinogenic agents
05/20/2003CA2131551C Conjugates formed from heat shock proteins and oligo- or polysaccharides
05/20/2003CA2075695C Monoclonal antibodies to sulfonated polymers
05/15/2003WO2003040695A2 Protein knobs
05/15/2003WO2003040394A2 Production of recombinant proteins in vivo and use for generating antibodies
05/15/2003WO2003040384A1 Recombinant antibodies for the detection and neutralization of anthrax toxin
05/15/2003WO2003040370A1 Weed controller metabolism proteins, genes thereof and use of the same
05/15/2003WO2003040352A1 Non-sporulating bacillus subtilis having parts of the gene encoding sigma g deleted
05/15/2003WO2003040345A2 Type 2 cytokine receptor and nucleic acids encoding same
05/15/2003WO2003040344A2 Transcription factor stress-related polypeptides and methods of use in plants
05/15/2003WO2003040341A2 Anti-hepatitis a virus antibodies
05/15/2003WO2003040335A2 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
05/15/2003WO2003040329A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/15/2003WO2003040316A2 Selective elimination of cd52+ cells and uses thereof
05/15/2003WO2003040313A2 Il-21 antagonists
05/15/2003WO2003040311A2 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4
05/15/2003WO2003040310A2 Novel epidermal growth factor protein and gene, and methods of use therefor
05/15/2003WO2003040309A2 Peptides acting as both glp-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
05/15/2003WO2003040307A2 Heteromultimeric tnf ligand family members
05/15/2003WO2003040188A1 Antibody stimulating il-1ra production
05/15/2003WO2003040187A1 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof
05/15/2003WO2003040179A1 High level constitutive production of anthrax protective antigen
05/15/2003WO2003040170A2 Antibodies to cd40
05/15/2003WO2003040169A2 Human monoclonal antibodies to dendritic cells
05/15/2003WO2003039489A2 Endocrine pancreas differentiation of adipose tissue-derived stromal cells and uses thereof
05/15/2003WO2003039462A2 B-cell lymphoma specific antigen for use in diagnosis and treatment of b-cell malignancies
05/15/2003WO2003039344A2 Methods and compositions for correction of cardiac conduction disturbances
05/15/2003WO2002097032A3 Proteins associated with cell growth, differentiation, and death
05/15/2003WO2002064795A3 Putative human enzymes
05/15/2003WO2002057451A9 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein
05/15/2003WO2002048366A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002048365A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/15/2003WO2002040654A3 A human serpin secreted from lymphoid cells lsi-01
05/15/2003WO2002029059A9 Nogo receptor homologs
05/15/2003WO2002029025A9 Factor vii glycoforms
05/15/2003WO2002016952A3 Detecting polymers and polymer fragments
05/15/2003WO2002014348A3 Glycoproteins and methods of use thereof
05/15/2003US20030093821 For therapy of human subject diagnosed for predisposition for increased serum cholesterol or LDL cholesterol
05/15/2003US20030093820 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
05/15/2003US20030093819 Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof
05/15/2003US20030092903 Nucleotide sequences coing polypeptide for use in the treatment, diagnosis and prevention of lymes's disease
05/15/2003US20030092897 Antigen composition against mycoplasma
05/15/2003US20030092891 Expressed ligand - vascular intercellular signalling molecule
05/15/2003US20030092886 Nucleotide sequences coding polypeptide for use in the treatment, prevention and diagnosis of tumors and cell proliferative disorders
05/15/2003US20030092883 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of cancer and nervous system disorders
05/15/2003US20030092882 Host cells containing multiple integrating vectors
05/15/2003US20030092645 Cloning, expression, viral and delivery vectors and hosts
05/15/2003US20030092624 Denaturant (boiling and/or detergent) stable; various uses including de-aggregating and/or preventing aggregation of an aggregating protein such as beta-amyloid or prions, restoring enzyme activity, and immunization using fusion protein
05/15/2003US20030092615 Nucleic acids, proteins, and antibodies
05/15/2003US20030092611 Nucleic acids, proteins, and antibodies
05/15/2003US20030092164 Polypeptide use in the treatment of cell proliferative disorders
1 ... 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 ... 1125